Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

522 TARTRAZINE
Reactions
Skin
Adverse effects (sic)
(1986): Stevenson DD+, J Allergy Clin Immunol 78(1 Pt 2), 182
(1982): Rosenhall L, Eur J Respir Dis 63(5), 410
(1981): Neumann CJ+, Am J Hosp Pharm 38(6), 790, 792
Allergic reactions (sic)
(2000): Bhatia MS, J Clin Psychiatry 61(7), 473
(1989): Pollock I+, BMJ 299(6700), 649
(1988): McLean JD, Can J Psychiatry 33(4), 331
(1987): Pohl R+, Am J Psychiatry 144(2), 237 (in antidepressents)
(1982): MacCara ME, Can Med Assoc J 126(8), 910
Angioedema
(1996): Jimenez-Aranda GS+, Rev Alerg Mex (Spanish) 43(6), 152
(1992): Novembre E+, Pediatr Med Chir (Italian) 14(1), 39
(passim)
(1989): Hong SP+, Yonsei Med J 30(4), 339
(1989): Montano Garcia ML, Rev Alerg Mex (Spanish) 36(3), 107
(1989): Montano Garcia ML+, Rev Alerg Mex (Spanish) 36(1), 15
(1985): Collins-Williams C, JAsthma22(3), 139 (aspirin
intolerance)
(1984): Diez Gomez ML+, Allergol Immunopathol (Madr)
(Spanish) 12(3), 179
(1981): Alvarez Cuesta E+, Allergol Immunopathol (Madr)
(Spanish) 9(1), 45
(1980): Makol GM+, Ariz Med 37(2), 79
Atopic dermatitis
(2001): Worm M+, Clin Exp Allergy 31(2), 265
(1992): Devlin J+, Arch Dis Child 67(6), 709
Dermatitis
(1990): Dipalma JR, Am Fam Physician 42(5), 1347
Edema
(1989): Pachor ML+, Oral Surg Oral Med Oral Pathol 67(4), 393
Fixed eruption
(1997): Orchard DC+, Australas J Dermatol 38(4), 212
Photosensitivity
Pruritus
(1981): Alvarez Cuesta E+, Allergol Immunopathol (Madr)
(Spanish) 9(1), 45
Purpura
(1999): Kalinke DU+, Hautarzt (German) 50(1), 47
(1993): Wuthrich B, Ann Allergy 71(4), 379
(1990): Dipalma JR, Am Fam Physician 42(5), 1347
(1985): Parodi G+, Dermatologica 171(1), 62
(1981): Alvarez Cuesta E+, Allergol Immunopathol (Madr)
(Spanish) 9(1), 45
Rash (sic)
(1995): Thuvander A, Lakartidningen (Swedish) 92(4), 296
Urticaria (often related to aspirin intolerance)
(1996): Jimenez-Aranda GS+, Rev Alerg Mex (Spanish) 43(6), 152
(1993): Wuthrich B, Ann Allergy 71(4), 379
(1992): Novembre E+, Pediatr Med Chir (Italian) 14(1), 39
(1990): Dipalma JR, Am Fam Physician 42(5), 1347
(1989): Baumgardner DJ, Postgrad Med 85(6), 265
(1989): Hong SP+, Yonsei Med J 30(4), 339
(1989): Montano Garcia ML, Rev Alerg Mex (Spanish) 36(3), 107
(1989): Montano Garcia ML+, Rev Alerg Mex (Spanish) 36(1), 15
(1989): Wilson N+, Clin Exp Allergy 19(3), 267
(1987): Settipane GA, N Engl Reg Allergy Proc 8(1), 39 (aspirin
intolerance)
(1986): Chudwin DS+, Ann Allergy 57(2), 133 (aspirin
intolerance)
(1986): Simon RA, N Engl Reg Allergy Proc 7(6), 533
(1986): Warrington RJ+, Clin Allergy 16(6), 527
(1985): Collins-Williams C, JAsthma22(3), 139 (aspirin
intolerance)
(1985): Podell RN, Postgrad Med 78(8), 83, 87, 92
(1984): Diez Gomez ML+, Allergol Immunopathol (Madr)
(Spanish) 12(3), 179
(1984): Royal College of Physicians and the British Nutrition
Foundation, J Royal College of Physicians of London 18(2)
(1982): Ortolani C+, Ann Allergy 48(1), 50
(1982): Warin RP+, Br Med J (Clin Res Ed) 284(6327), 1443
(1981): Alvarez Cuesta E+, Allergol Immunopathol (Madr)
(Spanish) 9(1), 45
(1981): Juhlin L, Br J Dermatology 104, 369
(1981): Wuthrich B+, Schweiz Med Wochenschr 111(39), 1445
(6.1%)
(1980): Makol GM+, Ariz Med 37(2), 79
(1980): Valverde E+, Clin Allergy 10(6), 691
Vasculitis
(1999): Kalinke DU+, Hautarzt (German) 50(1), 47
(1993): Wuthrich B, Ann Allergy 71(4), 379
(1990): Dipalma JR, Am Fam Physician 42(5), 1347
Mucosal
Gingival hyperplasia/hypertrophy
(1989): Pachor ML+, Oral Surg Oral Med Oral Pathol 67(4), 393
Other
Anaphylactoid reactions/Anaphylaxis
(1993): Wuthrich B, Ann Allergy 71(4), 379
(1989): Montano Garcia ML, Rev Alerg Mex (Spanish) 36(3), 107
(1981): Desmond RE+, Ann Allergy 46(2), 81
(1981): Schneiweiss F, Ann Allergy 46(5), 294
(1980): Kallos P+, Med Hypotheses 6(5), 487
Hypersensitivity
(1995): Sakakibara H+, Nihon Kyobu Shikkan Gakkai Zasshi
(Japanese) 33, 106
(1995): Thuvander A, Lakartidningen (Swedish) 92(4), 296
(1980): Weliky N+, Clin Allergy 10(4), 375
Serum sickness
Note: Tartrazine intolerance has been estimated to affect between
0.01% and 0.1% of the population. Adverse reactions are most
common in people who are sensitive to aspirin. Banned in Norway
and Austria
TEA TREE
Scientific names: Melaleuca alternifolia; Melaleuca cajeputi;
Melaleuca dissitifolia; Melaleuca linafolia
Family: Myrtaceae
Trade and other common names: Amber Gold; Australian
Tea Tree; Burnaid; Cajuput; Dessert Essence; Melasol; New
Zealand Manuka,; New Zealand Ti-Tree; Teatree oil
Category: Antiseptic
Purported indications and other uses: Gram-negative and
Gram-positive bacteria, acne, vaginal infection, burns,
onychomycosis, tinea pedis, bruises, insect bites, skin infections,
mouthwash, genital herpes, antiperspirant, gingivitis, disinfectant,
scabies
Half-life: N/A
Clinically important, potentially hazardous interactions
with: colophony, turpentine
Reactions
Skin
Adverse effects (sic)
(2002): Haller CA+, Adverse Drug React Toxicol Rev 21(3), 143
Allergic reactions (sic)
(2002): Haller CA+, Adverse Drug React Toxicol Rev 21(3), 143